A Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Participants With Colorectal Cancer

NCT00437268 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer
Colorectal Carcinoma
Colorectal Tumor

Interventions

DRUG: enzastaurin
DRUG: irinotecan
DRUG: cetuximab

Sponsor

Eli Lilly and Company